States use Preferred Drug Lists, pharmacist substitution rules, and copay differences to push generic drug use. These policies save billions without compromising care - but unintended rebate rules are putting some generics at risk.
In my latest blog post, I discussed the crucial role of cycloserine in managing multidrug-resistant tuberculosis (MDR-TB). Cycloserine, an antibiotic, has become increasingly important in the treatment of MDR-TB, especially when other first-line medications are ineffective. This is because it targets the bacteria causing TB in a different way, thus overcoming resistance. However, it's essential to use cycloserine in combination with other antibiotics to ensure maximum effectiveness and minimize the risk of further resistance. Overall, cycloserine plays a vital role in the fight against MDR-TB, and ongoing research is crucial to optimize its use and develop new treatments.
Learn how to manage nausea and prevent weight loss during chemotherapy with science-backed nutrition tips. Discover what to eat, what to avoid, and how to get enough protein and calories-even when you feel awful.
Partial AUC is a sophisticated pharmacokinetic tool used to assess bioequivalence in complex drug formulations where traditional metrics like Cmax and total AUC fall short. It measures drug exposure during clinically relevant time windows, ensuring generics match brand drugs in both timing and effect.
Medication errors cause over 1.5 million injuries and 7,000 deaths yearly in the U.S. Learn how hospitals use barcode systems and reconciliation to cut mistakes-and what you can do at home to protect yourself and loved ones.
Why do cheaper drugs seem less effective? Research shows price affects perception, not actual efficacy. Learn how psychology, FDA standards, and doctor communication shape drug choices.